| € millions | See Note | 2023 | 2022 |
| Sales | 6 | 41,420.5 | 39,408.9 |
| Cost of sales1,2 | -32,612,6 | -31,827.6 | |
| Gross margin on sales1,2 | 8,808.0 | 7,581.3 | |
| Research and development expenses1,2 | 7 | -4,125.7 | -4,056.8 |
| Selling and logistics expenses1,2 | -2,527.7 | -2,412.4 | |
| Administrative expenses1 | -1,354.9 | -1,091.7 | |
| Other income1 | 8 | 1,837.0 | 1,851.2 |
| Other expenses1 | 8 | -829.2 | -1,145.9 |
| Income from equity-accounted investees | 10 | 45.3 | 28.3 |
| Other income from investments | 10 | 1,2 | 0.8 |
| EBIT | 1,853.8 | 754.8 | |
| Interest income | 11 | 103.4 | 83.6 |
| Interest expense | 11 | -419.4 | -234.8 |
| Effects from currency translation | 11 | 78.8 | -59.6 |
| Effects from changes in the fair value of derivative instruments, and other valuation effects | 11 | 1.4 | 12.8 |
| Financial result | 11 | -235.8 | -198.0 |
| Earnings before tax | 1,618.0 | 556.8 | |
| Income tax expense | 12 | -424.1 | -444.6 |
| Net income | 1,193.9 | 112.2 | |
| Non-controlling interests | -37.5 | -45.5 | |
| Net income attributable to the shareholders of the parent | 1,156.4 | 66.6 | |
| Basic earnings per share in € | 38 | 5.78 | 0.33 |
| Diluted earnings per share in € | 38 | 5.78 | 0.33 |
1 In the year under review, the presentation of income and expenses in connection with specific warranties, restructuring measures, severance payments, as well as impairment and reversal of impairment losses on intangible assets and property, plant and equipment was changed. They are now assigned to the relevant functional areas. The comparative period has been adjusted accordingly.
2 The assignment of income and expenses from certain business activities within the functional areas has been adjusted. The comparative period has been adjusted accordingly
